Inventor · disambiguated record
Jacob Swidorski
Also filed as: SWIDORSKI JACOB
24 granted patents·8 pending applications·147 citations·filing 2007–2022
95Inventor score
Files withBRISTOL MYERS SQUIBB CO11VIIV HEALTHCARE UK NO 5 LTD10REGUEIRO-REN ALICIA5VIIV HEALTHCARE UK NO 4 LTD5WANG TAO1
Top patents by PatentIndex Score
32 records- 0194US7807671B2Diketo-piperazine and piperidine derivatives as antiviral agentsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Oct 5, 2010·29 cites·6 claims
- 0293US9527882B2Triterpenoids with HIV maturation inhibitory activityVIIV HEALTHCARE UK (NO 4) LTD·Filed 2015·Granted Dec 27, 2016·6 cites·18 claims
- 0392US8846647B2C-17 and C-3 modified triterpenoids with HIV maturation inhibitory activityREGUEIRO-REN ALICIA·Filed 2012·Granted Sep 30, 2014·19 cites·16 claims
- 0492US7807676B2Diketo-Piperazine and Piperidine derivatives as antiviral agentsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Oct 5, 2010·17 cites·22 claims
- 0589US8754068B2Modified C-3 betulinic acid derivatives as HIV maturation inhibitorsREGUEIRO-REN ALICIA·Filed 2011·Granted Jun 17, 2014·15 cites·24 claims
- 0689US8748415B2C-28 amines of C-3 modified betulinic acid derivatives as HIV maturation inhibitorsREGUEIRO-REN ALICIA·Filed 2012·Granted Jun 10, 2014·16 cites·15 claims
- 0788US8906889B2C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activityBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Dec 9, 2014·12 cites·19 claims
- 0888US8802661B2C-28 amides of modified C-3 betulinic acid derivatives as HIV maturation inhibitorsREGUEIRO-REN ALICIA·Filed 2011·Granted Aug 12, 2014·14 cites·22 claims
- 0988US7960406B2Diketo substituted pyrrolo[2,3-c] pyridinesBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Jun 14, 2011·5 cites·4 claims
- 1087US11267811B2Small molecule inhibitors of galectin-3BRISTOL MYERS SQUIBB CO·Filed 2018·Granted Mar 8, 2022·4 cites·20 claims
- 1185US11084845B2C-3 and C-17 modified triterpenoids as HIV-1 inhibitorsVIIV HEALTHCARE UK NO 5 LTD·Filed 2019·Granted Aug 10, 2021·1 cites·8 claims
- 1283US10421774B2C-3 and C-17 modified triterpenoids as HIV-1 inhibitorsVIIV HEALTHCARE UK NO 5 LTD·Filed 2017·Granted Sep 24, 2019·1 cites·4 claims
- 1382US8124615B2Diketo substituted pyrrolo[2,3-C]pyridinesWANG TAO·Filed 2011·Granted Feb 28, 2012·3 cites·6 claims
- 1477US8242124B2Diketopiperidine derivatives as HIV attachment inhibitorsREGUEIRO-REN ALICIA·Filed 2009·Granted Aug 14, 2012·3 cites·15 claims
- 1577US2023295220A1C-3 and c-17 modified triterpenoids as hiv-1 inhibitorsVIIV HEALTHCARE UK NO 5 LTD·Filed 2022·Application pending·0 cites
- 1676US10780102B2Triterpenoids with HIV maturation inhibitory activityVIIV HEALTHCARE UK NO 4 LTD·Filed 2019·Granted Sep 22, 2020·0 cites·3 claims
- 1775US11464790B2Triterpenoids with HIV maturation inhibitory activityVIIV HEALTHCARE UK NO 4 LTD·Filed 2020·Granted Oct 11, 2022·0 cites·3 claims
- 1873US9969767B2Oxolupene derivativesVIIV HEALTHCARE UK NO 5 LTD·Filed 2015·Granted May 15, 2018·1 cites·6 claims
- 1972US8889854B2C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activityBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Nov 18, 2014·1 cites·18 claims
- 2071US2021323997A1C-3 and c-17 modified triterpenoids as hiv-1 inhibitorsVIIV HEALTHCARE UK NO 5 LTD·Filed 2021·Application pending·0 cites
- 2169US10245275B2Triterpenoids with HIV maturation inhibitory activityVIIV HEALTHCARE UK NO 4 LTD·Filed 2017·Granted Apr 2, 2019·0 cites·4 claims
- 2265US2017056420A1Triterpenoids with hiv maturation inhibitory activityVIIV HEALTHCARE UK (NO 4) LTD·Filed 2016·Application pending·0 cites
- 2359US2014343000A1Compositions having c-17 and c-3 modified triterpenoids with hiv maturation inhibitory activityBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 2454US12275718B2Small molecule inhibitors of galectin-3BRISTOL MYERS SQUIBB CO·Filed 2019·Granted Apr 15, 2025·0 cites·16 claims
- 2550US9249180B2C-3 alkyl and alkenyl modified betulinic acid derivativesBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Feb 2, 2016·0 cites·13 claims
- 2650US2016151387A1Compositions having c-17 and c-3 modified triterpenoids with hiv maturation inhibitory activityBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 2747US10493070B2Azadecalin derivatives as inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2017·Granted Dec 3, 2019·0 cites·8 claims
- 2845US2019135857A1Triterpenoid inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2017·Application pending·0 cites
- 2945US2014221361A1C-19 modified triterpenoids with hiv maturation inhibitory activityBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 3043US9914747B2Extended betulinic acid analogsVIIV HEALTHCARE UK NO 5 LTD·Filed 2015·Granted Mar 13, 2018·0 cites·6 claims
- 3141US2019307776A1Aza-substituted inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2017·Application pending·0 cites
- 3238US9920090B2Betulinic acid derivatives with HIV maturation inhibitory activityVIIV HEALTHCARE UK NO 5 LTD·Filed 2015·Granted Mar 20, 2018·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Jacob Swidorski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →